Novo Industri AS–1981

Case Analysis

The small but fast-growing Danish biochemical company needs to choose the financing include euro convertible bond, a rights offering in Denmark and an issue of new ordinary shares in the United States in several ways. The case concerns a wide range of issues related to the ability of a multinational company to reduce the cost of capital by tapping different world capital markets.

The small but fast-growing Danish biochemical company needs to choose the financing include euro convertible bond, a rights offering in Denmark and an issue of new ordinary shares in the United States in several ways. The case concerns a wide range of issues related to the ability of a multinational company to reduce the cost of capital by tapping different world capital markets.
«Hide

from
W. Carl Kester
Source: Harvard Business School
12 pages.
Publication Date: Feb 18, 1986. Prod #: 286084-PDF-ENG
Novo Industri A/S–1981 HBR case solution